Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: "There is no mention of cost. The story could have at least reported what the drug costs in its current use against blood cancer. The story did a good job of explaining both the potential benefits and harms of the drugs. This was a particular strength of this story – and made it stand out in comparison with the LA Times blog story that we also reviewed. Harms were emphasized from the outset – even in the headline – in the AP story but were never mentioned in the LA Times story. And this story reminded readers of the side effects encountered with another MS drug, Tysabri. Outstanding job on this issue by the AP. The story did a very good job of explaining the studies. There is no sign of disease-mongering in this story. Two apparently independent sources were quoted. The story did a good job comparing the new drugs with existing approaches to treat MS. Story explains that the drug is already sold to treat a rare blood cancer and stated that ""it’s too soon to know if the pills will be approved by the government or widely adopted by physicians."" It does not report, however, as the LA TImes blog did, that ""The drug company MD Serono, an affiliate of Merck, has requested approval from the Food and Drug Administration to market the tablet. However it recently received a ""refuse to file"" letter from the FDA, which means the agency is requiring additional information or data. MD Serono said it is pursuing the matter with the FDA and hopes to re-submit its application."" We think that’s a crucial piece of information that affects availability, although, of course, doctors can still prescribe it for off-label use even before the FDA acts on the new request. The novelty of ""tests of the first two oral drugs developed for treating MS"" was clear in the story. It is clear that this story did not rely on a news release."
[A]: MS pills show promise and risk, studies say


[Q]: Israel has seen five deaths and close to 2,400 cases so far. Citizens hoping for a stroll or jog were instructed earlier on Wednesday to stay within 100 metres (110 yards) of their homes for a week under tightened restrictions to curb the contagion. The new restrictions further reduced public transport, required employers to check workers for fever and set sanctions for people who defy rules. Israelis have been instructed to stay home where possible, schools have been shut and many businesses have closed, prompting more than 500,000 lay-offs. “If we do not see an immediate improvement in the trendline there will be no avoiding a full closure,” Netanyahu said in televised remarks. “(The decision) is a matter of a few days (away). And we are making all of the preparations for it.”   The sight of people, out for fresh air, jogging and congregating on city streets has alarmed health authorities. The new 100-metre limit is meant to end such activity. The private sector has had to limit employees at the workplace to 10 people or 30% of the company’s workforce, and most of the public sector has been put on leave. Israelis, though, could still drive themselves to work or to shops for essentials under the new restrictions, and food delivery services were operating. Penalties ranging from fines to a six-month jail term were set for anyone defying the orders. Israel’s central bank on Tuesday projected an economic contraction of 2.5% in 2020 as long as the partial lockdown eases by the end of April. In his remarks, Netanyahu said his caretaker government was setting up an economic plan to help businesses and the self-employed, and that a team was set-up to prepare for the day after the virus ends. The coronavirus crisis comes as Israel is grappling with political deadlock after three inconclusive elections in less than a year. Netanyahu’s centrist political rival, former military chief Benny Gantz, has been tasked with forming a new coalition government. But neither Gantz nor Netanyahu won a stable parliamentary majority in the March 2 election and negotiations to form a unity government comprising both their parties have come to a halt in the past few days.
[A]: Israel's Netanyahu says complete lockdown unavoidable unless new infections ebb.


[Q]: No discussion of costs, something we always look for and wish would be provided. As already noted, the story explained that the drug “isn’t a magic bullet. The study showed that 37 percent of women who got weekly injections of it delivered prematurely, compared to 55 percent of women who got injections of a placebo.” Good discussion of concerns and ongoing monitoring of the drug’s safety. The story explains the drug “isn’t a magic bullet. The study showed that 37 percent of women who got weekly injections of it delivered prematurely, compared to 55 percent of women who got injections of a placebo.” No disease-mongering of prematurity or its consequences. The medical director of The March of Dimes was quoted throughout. (Although they are seen as having a very pro-progesterone slant that is not held by consumer/advocacy/health policy/maternity care groups in UK, Australia, and Canada. in those countries surveys of providers uniformly get low utilization responses with the reason stated being need for more data. Similar surveys of US providers (specialty and generalists) show the vast majority use >70% (as opposed to low double digits in more evidence-driven countries) and that mission creep has started. Indications for which it is not tested see regular use in the US.) There was at least the historical perspective on “the last drug thought to prevent premature birth – a synthetic estrogen called diethylstilbesterol, or DES.” The focus of the story is FDA approval of the drug. Good historical context, explaining that “Interestingly, the drug is not new — it’s just taken a long and circuitous route to approval.” It’s clear the story didn’t rely solely on a news release.
[A]:
FDA Approves First Drug To Prevent Preterm Births